Changes in lung function in acute COPD

S. C. Bourne, B. Green, A. M. McMahon, T. Cumberbatch, O. Elsworth, J. W. Millar, S. D. Crowther (Poole, United Kingdom)

Source: Annual Congress 2003 - Management of acute exacerbations in COPD
Session: Management of acute exacerbations in COPD
Session type: Thematic Poster Session
Number: 1594
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. C. Bourne, B. Green, A. M. McMahon, T. Cumberbatch, O. Elsworth, J. W. Millar, S. D. Crowther (Poole, United Kingdom). Changes in lung function in acute COPD. Eur Respir J 2003; 22: Suppl. 45, 1594

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of lung hyperinflation on cardiac function during acute exacerbations of COPD
Source: Virtual Congress 2020 – From respiratory physiology to diagnosis and treatment
Year: 2020


Changes in lung function in patients with acute COPD exacerbations: spirometry vs. forced oscillations
Source: Eur Respir J 2001; 18: Suppl. 33, 149s
Year: 2001

Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Why does chronic bronchitis and lung infection accelerate lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021


Relationship between improvement in dyspnoea and change in lung function in obstructive lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 137s
Year: 2001

Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Relationship of cardiac biomarkers in COPD to exacerbation and hyperinflation
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 566s
Year: 2003

Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002

Changes in functional capacity after endoscopic lung volume reduction in patients with chronic obstructive lung disease and severe emphysema
Source: International Congress 2018 – Endoscopic lung volume reduction
Year: 2018

Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006


The relationship of dyspnea and lung function at COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002

Monitoring of pediatric asthma by symptoms and lung function versus symptoms, lung function and exhaled NO
Source: Annual Congress 2004 - Monitoring childhood asthma
Year: 2004


Relationship between respiratory exchange ratio and pulmonary function in patients with obstructive lung disease
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021

The relationship of exacerbations and lung function decline to radiologic characteristics in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

Relationship of airway dimensions with lung volumes in chronic obstrucive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 655s
Year: 2006

Bronchodilator response of advanced lung function parameters depending on COPD severity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016